Last updated on June 2019

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis


Brief description of study

This study will assess the efficacy and safety of MSTT1041A in participants with moderate to severe atopic dermatitis (AD). The study consists of a screening period, a 16-week treatment period, and an 8-week follow-up period.

Clinical Study Identifier: NCT03747575

Find a site near you

Start Over

Alabama Allergy & Asthma

Birmingham, AL United States
  Connect »

Jonathan Corren MD, Inc.

Los Angeles, CA United States
  Connect »

Clinical Science Institute

Santa Monica, CA United States
  Connect »

Asthma & Allergy; Associates, P.C.

Colorado Springs, CO United States
  Connect »

Harmony Clinical Research, Inc

North Miami Beach, FL United States
  Connect »

GCP Global Clinical Professionals

Saint Petersburg, FL United States
  Connect »

Forward Clinical Trials

Tampa, FL United States
  Connect »

DS Research

New Albany, IN United States
  Connect »

Clinical Research of Charlotte

Charlotte, NC United States
  Connect »

Center for Clinical Studies

Houston, TX United States
  Connect »

Grey Canyon Family Medicine PA

San Antonio, TX United States
  Connect »

Laser Clinic

Szczecin, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.